Revealing new mechanistic insights into the multiple facets of why factor VIII inhibitors form as an immune response to protein replacement therapy to treat hemophilia A.
The Mechanistic Molecular Immunology Lab integrates cutting-edge structural biology and biochemistry tools with functional immunoassays to understand the molecular basis of immune responses to viral infections and tumors, with an emphasis on the development of novel protein-based therapeutics.
